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he 
 
 
 
1(X) collagen gene (
 
Col10a1
 
) is the only known
hypertrophic chondrocyte–speciﬁc molecular marker.
Until recently, few transcriptional factors specifying
its tissue-speciﬁc expression have been identiﬁed. We
 
show here that a 4-kb murine 
 
Col10a1
 
 promoter can
 
drive 
 
 
 
-galactosidase expression in lower hypertrophic
chondrocytes in transgenic mice. Comparative genomic
 
analysis revealed multiple 
 
Runx2 
 
(Runt domain transcription
factor)
 
 
 
binding sites within the proximal human, mouse,
and chick 
 
Col10a1
 
 promoters. In vitro transfection studies
and chromatin immunoprecipitation analysis using hyper-
T
 
trophic MCT cells showed that 
 
Runx2
 
 contributes to the
transactivation of this promoter via its conserved 
 
Runx2
 
binding sites. When the 4-kb 
 
Col10a1
 
 promoter transgene
 
was bred onto a 
 
Runx2
 
 
 
/
 
 
 
 background, the reporter was
expressed at lower levels. Moreover, decreased 
 
Col10a1
 
expression and altered chondrocyte hypertrophy was also
 
observed in 
 
Runx2
 
 heterozygote mice, whereas 
 
Col10a1
 
was barely detectable in
 
 Runx2
 
-null mice. Together, these
data suggest that 
 
Col10a1
 
 is a direct transcriptional target
of 
 
Runx2
 
 during chondrogenesis.
 
Introduction
 
Type X collagen gene (
 
Col10a1
 
) is the only known hyper-
trophic chondrocyte–specific molecular marker. Mutations
in 
 
COL10A1
 
 in humans have been associated with Schmid
metaphyseal chondrodysplasia (SMCD; Warman et al.,
1993). It has also been reported that 
 
Col10a1
 
-null mice have
subtle growth plate compressions partially resembling
SMCD (Kwan et al., 1997). However, the molecular mech-
anisms conferring its tissue-specific expression pattern are
still poorly understood. Although in vitro transfection stud-
ies of the human and mouse promoters have identified puta-
tive cis regulatory elements (Beier et al., 1997; Riemer et al.,
2002), transgenic mouse studies have not yielded tissue-
specific expression using murine control elements (Eerola et
al., 1996). Comparative sequence analysis demonstrates a
high level of conservation between murine, human, and
chick promoters in the immediate vicinity of the start site of
transcription (
 
 
 
120 to 
 
 
 
1 bp) identifying this as the likely
basal promoter (Beier et al., 1996). However, whereas a
transgenic reporter mouse line containing 1.7 kb of the chick
promoter resulted in tissue-specific expression in hyper-
trophic chondrocytes (Jacenko et al., 1993), the similar murine
construct containing the corresponding mouse promoter
resulted in expression within the soft connective tissues, but
not in the hypertrophic chondrocytes, suggesting that sequence
divergence from chick to humans and mice resulted in trans-
position of the tissue-specific cis regulatory element to another
region of the promoter (Eerola et al., 1996). Several in vitro
transfection/reporter studies using the human 
 
COL10A1
 
promoter have suggested the existence of negative regulatory
elements in the distal promoter (
 
 
 
2.8 to 
 
 
 
2.4 kb), which
are active in resting chondrocytes and nonchondrogenic cell
lines, whereas a hypertrophic chondrocyte cell type–specific
enhancer element resides in 
 
 
 
2.4 to 
 
 
 
0.9 kb region (Beier
et al., 1997). Similar types of studies with chick 
 
Col10a1
 
confirmed the importance of both negative and positive reg-
ulatory sequences in the chick proximal 4.4-kb promoter
(Dourado and LuValle, 1998). Finally, a recent study of the
human promoter identified a c-fos responsive element that
might mediate parathyroid hormone/parathyroid hormone
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related peptide regulation of 
 
COL10A1 
 
gene expression
(Riemer et al., 2002). These data show that at least
 
 
 
in cell
culture, multiple cis elements together specify high level
gene expression in hypertrophic chondrocytes.
Although several signaling molecules including Indian
Hedgehog and parathyroid hormone related peptide have
been shown to be required for chondrocyte hypertrophy by
mouse genetic studies, few transcriptional determinants
specifying hypertrophic chondrocyte–specific type X col-
lagen gene expression have been identified to date (Karaplis
et al., 1994; Schipani et al., 1995, 1997; Lanske et al., 1996;
Vortkamp et al., 1996; St-Jacques et al., 1999; Chung et al.,
2001). One candidate gene likely important for 
 
Col10a1
 
gene regulation is the runt domain transcription factor
 
Runx2/Cbfa1
 
. 
 
Runx2
 
 has been shown in mouse genetic stud-
ies to be required for differentiation of the mesenchymal
stem cell into the osteoblast lineage (Komori et al., 1997;
Otto et al., 1997). 
 
Runx2
 
-null mice do not have bone and
accordingly 
 
Runx2
 
 has also been demonstrated to transacti-
vate a host of genes highly expressed in osteoblasts including
osteocalcin and type I collagen (Ducy et al., 1997). 
 
Runx2
 
has also been shown to be important for chondrocyte differ-
entiation, i.e., during endochondral ossification. Supporting
this are recent histomorphologic studies showing alteration
of chondrocyte maturation in some long bones of 
 
Runx2
 
-
null mice as well as cell culture studies indicating that 
 
Runx2
 
is a positive regulatory factor for chondrocyte maturation
(Inada et al., 1999; Kim et al., 1999; Enomoto et al., 2000).
In fact, two studies mis-expressing 
 
Runx2
 
 in proliferating
chondrocytes were able to induce chondrocyte hypertrophy
and partially rescue 
 
Runx2
 
-null mice (Takeda et al., 2001;
Ueta et al., 2001). Although recent studies have demon-
strated several transcriptional targets for 
 
Runx2
 
 in osteoblas-
tic and chondrocytic cells (Jimenez et al., 1999; Zelzer et al.,
2001), the direct link between 
 
Runx2 
 
and the tissue-specific
expression of type X collagen, the only known hypertrophic
chondrocyte–specific molecular marker, has not been identi-
fied yet.
Here, we present identification of the first murine
 
Col10a1
 
 promoter that can direct reporter activity selectively
in hypertrophic chondrocytes in transgenic mice. We fur-
ther show that 
 
Runx2
 
 can directly transactivate this 
 
Col10a1
 
promoter both in vitro and in vivo via putative 
 
Runx2
 
 bind-
ing sites found in this promoter region. Last, we discussed
the altered endochondral ossification in the 
 
Runx2
 
 mutant
mice. We surmise that this is probably due to down-regula-
tion of 
 
Runx2
 
 targets in the hypertrophic chondrocytes in-
cluding 
 
Col10a1
 
.
 
Results
 
Comparative genomic analysis of type X collagen 
gene promoter
 
We isolated a murine 
 
Col10a1
 
 containing BAC clone. Se-
quence analysis on the 5
 
 
 
 promoter region revealed several
putative 
 
Runx2
 
 binding sites (PuACCPuCA or TGTGGT;
Ducy et al., 1997; Jimenez et al., 1999). Then we per-
formed comparative genome analysis of type X collagen
gene promoter across species. Multiple potential 
 
Runx2
 
binding sites were also observed within 5 kb of the human
 
and chicken 
 
Col10a1
 
 promoters (Fig. 1, A and B). Interest-
ingly, no significant conservation within long stretches of
sequences flanking the 
 
Runx2
 
 binding sites was observed
between the human and mouse type X collagen genes.
However, immediate flanking sequences, i.e., 10 bp on
either side of sites 
 
 
 
3485 and 
 
 
 
2379 bp (A and B ele-
ments; Fig. 1 A and Fig. 2 A) in the mouse 
 
Col10a1
 
 gene,
showed 60–70% homology between the human and mu-
rine 
 
Col10a1
 
 promoter region (Fig. 1 C).
 
4-kb 
 
Col10a1
 
 murine promoter can direct expression 
in hypertrophic chondrocytes both in vitro and in vivo
 
To study whether a 4-kb 
 
Col10a1
 
 promoter containing the
conserved Runx2 binding sites A and B is in fact up-regulated
during chondrocyte hypertrophy in vitro, we measured the
activity of a reporter construct containing this 4-kb promoter
in hypertrophic MCT cells (Fig. 2 A). MCT cells are mouse
chondrocytes that have been immortalized with a tempera-
ture-sensitive mutant of SV40 large T antigen. Although they
proliferate at a permissive temperature of 32
 
 
 
C, MCT cells
Figure 1.  Comparative genomic analysis of type X collagen gene 
promoter. (A) Schematic illustration of human, mouse and chicken 
Col10a1 promoter. Putative Runx2 binding sites within the promoter 
region are indicated by yellow triangle. The two conserved sites A 
and B between human and mouse are highlighted as red triangle. 
(B) Sequence and position of the potential Runx2 binding sites 
within 5-kb of the human, mouse, and chick Col10a1 promoter. 
The putative RUNX2 binding sequence and their position within the 
type X promoter are shown in the Table. There are 7, 4 and 5 potential 
RUNX2 binding sites within 5-kb of the human, mouse, and chicken 
Col10a1 promoters, respectively. (C) Sequence comparison between 
mouse and human A and B elements. The sequence including the 
mouse A and B elements and 10 bp of immediate flanking sequence 
show 60–70% homology to the corresponding human elements. 
No significant similarity was found among other putative RUNX2 
binding sites (not depicted). Core sequences of the putative RUNX2 
binding sites are underlined. Bars represent identical nucleotides 
and vertical dots represent conserved nucleotide base pairing.T
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terminally differentiate and become hypertrophic and specifi-
cally express type X collagen and other hypertrophic chon-
drocyte markers when grown at the nonpermissive tempera-
ture of 37
 
 
 
C (Lefebvre et al., 1995). Indeed, Northern
analysis showed that MCT cells expressed type X collagen
when cultured at 37
 
 
 
C but not at 32
 
 
 
C (Fig. 2 B, left; Le-
febvre et al., 1995). We transfected the 
 
Col10a1
 
 4-kb pro-
moter driving the 
 
 
 
-galactosidase reporter into MCT cells.
Consistent with significant up-regulation of endogenous
 
Col10a1
 
 gene expression in hypertrophic MCT cells, 
 
 
 
-galac-
tosidase activity was increased 42-fold compared to the activ-
ity in proliferating MCT chondrocytes (Fig. 2 B, right).
To determine the in vivo relevance of these data, we gen-
erated four independent transgenic mouse lines harboring the
4-kb proximal 
 
Col10a1
 
 promoter upstream of the 
 
 
 
-galac-
tosidase reporter gene. Three lines of mice exhibited similar
X-gal staining, whereas the fourth one did not show any
staining. We performed whole embryo staining of E15.5
mouse embryos and blue staining was noted only at the ends
of long bones (Fig. 3 A). No blue staining was observed in
any other tissues when analyzing sagittal sections of the
whole embryos featuring a variety of tissues (unpublished
data). Although some background staining in craniofacial
region probably due to endogenous 
 
 
 
-galactosidase, activity
was observed both in transgenic and control postnatal day 1
(P1) mice, specific blue staining was observed only in the
chondro-osseus junction of limbs, ribs and also in the nasal
cartilage of transgenic mice (Fig 3 B). Indeed, histological
analysis confirmed that 
 
 
 
-galactosidase expression was ob-
served in the lower zone of hypertrophy of rib sections and
in the long bone sections of the limbs including proximal
humerus and proximal femur at P1 stage (Fig. 3, C and E,
and not depicted). Although some weak staining was also
present in bone marrow along trabeculae presumably in os-
teoblasts, no blue staining was observed in other tissues in-
cluding perichondrium, resting or proliferating chondro-
cytes, muscle fibers, or adhering connective tissues (Fig. 3 B
and not depicted). These data show that the proximal 4-kb
 
Col10a1 
 
promoter was able to direct hypertrophic chondro-
cyte expression of the 
 
 
 
-galactosidase reporter in vivo and,
therefore, contributes to 
 
Col10a1
 
 expression in these cells.
Because a 1.7-kb mouse promoter was previously reported
to be unable to direct expression of 
 
 
 
-galactosidase to hyper-
trophic chondrocytes (Eerola et al., 1996), we hypothesized
that the positive regulatory elements in this 4-kb construct
most likely reside in the 5
 
 
 
 portion where the two conserved
 
Runx2
 
 binding sites A and B are found.
 
Runx2
 
 regulates transcription of 
 
Col10a1 
 
via Runx2 
binding elements within Col10a1 promoter
Electrophoretic mobility shift assays (EMSA) showed that
His-tagged recombinant DNA-binding RUNT domain
polypeptide bound to each of the putative RUNX2 binding
sites A and B found in the Col10a1 promoter (Fig. 4 A). As
expected, mutations within the core binding sequences abol-
ished binding, whereas mutations outside of the core se-
quence had no significant effect on formation of the DNA–
protein complex (Fig. 4 A). EMSA, using nuclear extracts
from hypertrophic MCT cells, showed DNA–protein com-
plexes specific for each of these two cis elements (Fig. 4 B).
These DNA–protein complexes were effectively competed
for by unlabeled probe. Moreover, the addition of anti-
Figure 2.  Col10a1 promoter and its upregulation in 
MCT cells. (A) Restriction map of murine Col10a1. 
Col10a1 is composed of three exons numbered I, II and 
III. Position of TATA box in the minimal promoter, ATG 
start codon, and TGA stop codon are marked. Positions of 
the two putative Runx2 binding elements are highlighted 
as A and B. The 4-kb promoter used in transgenic mice 
studies is indicated below by arrows. E, EcoRI; Xh, XhoI; 
K, KpnI. (B) Endogenous Col10a1 mRNA and Col10a1 
4-kb promoter activity are up-regulated in hypertrophic 
MCT cells. (left) Northern analysis of Col10a1 expression 
from MCT cells grown for 3 d at either 32 C or 37 C. 
Loading was normalized by hybridization with Gapdh. 
Col10a1 was expressed abundantly in hypertrophic MCT 
cells at 37 C but not in proliferating MCT cells at 32 C. 
(right) Col10a1-SA geobpA reporter plasmid was trans-
fected into MCT cells grown at 32 C and then further 
cultured at either 32 C or 37 C. A RSV-luc luciferase 
expression plasmid was cotransfected as internal control 
for transfection efficiency. Bars represent the average 
ratios of  -galactosidase to luciferase activity. The standard 
deviations from three independent transfections of one rep-
resentative experiment are indicated by the error bars.T
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Runx2 antibody resulted in the formation of a new low mo-
bility complex, suggesting that Runx2 is able to bind the
DNA elements and might be a component of the higher mo-
bility complex(es) formed in the absence of antibody (Fig. 4
B). Interestingly, the EMSA with MCT nuclear extracts
showed two complexes that were both effectively competed
for by cold probe suggesting that different molecular com-
plexes may form on these cis elements. The two additional
putative Runx2 binding sites in the mouse 4-kb promoter
bound RUNX2 weakly and the addition of antibody did not
generate bands of delayed mobility (unpublished data).
To test whether Runx2 interacts with Col10a1 promoter
via A and B elements in vivo, we also performed chromatin
immunoprecipitation analysis using hypertrophic MCT cells
and Runx2 antibody. Indeed, we were able to coimmuno-
precipitate both A and B elements with Runx2 antibody but
not with control antibody. Furthermore, a 300-bp Col10a1
intron II fragment, which does not contain a Runx2 site,
could not be immunoprecipitated with Runx2 antibody.
These results indicated that Runx2 binds to A and B ele-
ments within Col10a1 promoter in vivo (Fig. 4 C).
In cotransfection studies in COS7 cells, RUNX2 was able
to transactivate reporter constructs containing eight copies
of either of these RUNX2-binding elements upstream of a
44-bp  Col10a1 minimal promoter and the luciferase re-
porter gene (Fig. 5 A). Promoter constructs containing the A
element or B element were transactivated  20- and 40-fold
above baseline, respectively (Fig. 5 A). These data show that
RUNX2 can bind to the distal sequences of the 4-kb
Col10a1 promoter and transactivate a Col10a1 minimal pro-
moter via these sequences. We also transfected the Col10a1
4-kb promoter- -galactosidase reporter plasmid with or
without the RUNX2 expression plasmid into hypertrophic
MCT cells. The endogenous activity of the 4-kb promoter
was 10-fold greater than that of the basal promoter (Fig. 5
B, left). In addition, when RUNX2 is over-expressed in
these cells, reporter activity is further upregulated more than
two-fold above the endogenous activity of this promoter
(Fig. 5 B, left). In converse, when the two RUNX2 binding
sites are mutated in the 4-kb promoter, reporter activity is
decreased by 35% compared to the wild-type promoter (Fig.
5 B, right). Together, these data show that the 4-kb Col10a1
promoter is up-regulated when MCT chondrocytes hyper-
trophy in culture and that RUNX2 binding contributes to
this transactivation.
To quantify the correlation between Runx2 and Col10a1
expression, quantitative real time RT-PCR was used to de-
termine their respective levels of expression in both the
Figure 3.  Col10a1 promoter activity in trans-
genic reporter mice. (A and B) X-gal stained E15.5 
(left) and postnatal day 1 (P1; right) transgenic 
mice line 41 showed blue staining in the chondro-
osseus junction (arrows) of mouse limbs and ribs 
but not in the wild-type littermate controls. Back-
ground staining probably due to endogenous
 -galactosidase activity was also observed in 
craniofacial region both in transgenic and control 
P1 mice. (C and E) Sagittal sections of proximal 
humerus and femur from P1 transgenic mouse line 
41 shows blue staining in lower hypertrophic zone. 
Although strongest staining is observed in the 
lower hypertrophic zone, weak staining is also 
occasionally present in the bone trabeculae. 
(D and F) Comparative sagittal sections from wild-
type littermates control show no staining. Tg, 
transgenic mice; Ctrl, wild-type littermate control; 
HZ, hypertrophic zone of growth plate.T
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MCT cells and in Runx2
 / , Runx2
 / , and Runx2
 /  mice
(Otto et al., 1997; Livak and Schmittgen, 2001; Pfaffl,
2001). Runx2 was weakly expressed in MCT cells grown at
32 C by Northern and qualitative RT-PCR analysis (un-
published data). However, when cells were terminally differ-
entiated by growth at nonpermissive temperatures (from
32 C to 37 C), Col10a1 was upregulated (Fig. 2 B, left, and
Fig. 6 A, right) in conjunction with a two fold up-regulation
of Runx2 (Fig. 6 A, left). In limbs from newborn mice, real
time RT-PCR assay showed less Col10a1 expression in
Runx2 heterozygotes ( 50%) compared to that of the wild-
type littermate controls (Fig. 6 B, right). Furthermore,
Col10a1 expression was at a level barely detectable in
Runx2
 /  mice limbs (Fig. 6 B, right; Inada et al., 1999). As
expected, Runx2 expression was decreased by 45% in Runx2
heterozygotes (Fig. 6 B, left). Thus, our data suggest that
Runx2 might directly regulate the activation of the type X
collagen gene during chondrocyte maturation in vivo.
Runx2 transactivates Col10a1 promoter in 
transgenic study
To further delineate the contribution of Runx2 to trans-
activation of Col10a1 in vivo, we bred the 4-kb promoter-
 -galactosidase transgene (Tg) onto a Runx2 heterozygote
background to generate four different genotypes for histo-
logical analysis: Tg
 / /Runx2
 / , Tg
 / /Runx2
 / , Runx2
 / ,
and Runx2
 /  (wild type; Otto et al., 1997). Sections of long
bones including the distal ulna and proximal tibia from P1
mice showed X-gal staining in hypertrophic chondrocytes in
Tg
 / /Runx2
 /  (Fig. 7 A and not depicted). X-gal staining
was decreased in Tg
 / /Runx2
 /  mice (Fig. 7 A). Although
the Runx2 targeted allele does contain a knock-in LacZ re-
porter, Runx2 expression in hypertrophic chondrocytes is
lower compared to its expression in osteoblasts and X-gal
blue staining in the Runx2
 / mice was undetectable in hy-
pertrophic chondrocytes with our protocol (Fig. 7 A, right).
As expected, X-gal staining was stronger in the bone mar-
row of Tg
 / /Runx2
 /  mice than in Tg
 / /Runx2
 /  mice
because of the strong LacZ expression of the Runx2 targeted
allele in osteoblast (unpublished data). To quantify and
compare the transgene expression in Tg/Runx2
 /  and Tg/
Runx2
 / mice, we performed semiquantitative densitomet-
ric analysis of transgene expression in mouse limb sections
(Ma et al., 2001). 200 blue-stained cells in the hypertrophic
zone from twenty limb sections from each of the genotype
were chosen for analysis. The gray value, which is inversely
related to the intensity of the blue staining, is significantly
lower in cells from Tg/Runx2
 /  mice limb sections than
that from Tg/Runx2
 / mice (P   0.01). This result sug-
gested that the transgene is expressed at a lower level in
chondrocytes from Tg/Runx2
 /  mice compared to that of
Tg/Runx2
 /  mice (Fig. 7 B, left). We also performed real
time RT-PCR quantification of transgene expression using
RNAs from transgenic mice limbs with Runx2 wild-type
(Tg/Runx2
 / ) or heterozygote background (Tg/Runx2
 / ).
Transgene expression decreased by approximately 40% in
Tg/Runx2
 /  compared to that of Tg/Runx2
 /  (Fig. 7 B,
right). These data support genetic interaction between the
Col10a1 Tg reporter allele and Runx2 expression in hyper-
Figure 4.  RUNX2 binds to cis elements A and B within Col10a1 
promoter region. (A) EMSA using His-tagged recombinant RUNX2 
Runt polypeptide with cis element A or B as probe (Fig. 1 A).
32P-End–labeled wild-type (WT) probe A or B (Fig. 1) and the probe 
mutated outside of the core sequence (MO) exhibited binding 
(arrow), whereas a mutation in the core sequence (MI) abolished 
binding. (B) EMSA using nuclear extracts from hypertrophic MCT 
cells grown at 37 C with A or B probe. Both 
32P-end–labeled wild-
type probe A or B (lane 1) shows two specific DNA–protein com-
plexes (arrows). These complexes diminish with competition with 
100-fold cold probe (lane 2). Presence of Runx2 in the DNA–protein 
complex is demonstrated by the formation of a new low mobility 
complex (arrowhead) with the addition of anti-Runx2 antibody to 
the MCT cell nuclear extracts (lane 3) but not in the control with 
preimmune serum (lane 4). (C) Runx2 binds to the mouse A and B 
elements in hypertrophic MCT cells. A representative chromatin 
immunoprecipitation experiment with hypertrophic MCT cells is 
shown. Immunoprecipitation was performed with anti-Runx2 anti-
body (lanes 2, 6, and 10), preimmune antiserum (lanes 3, 7, and 11) 
or no antibody (lanes 4, 8, and 12). Following DNA purification, 
samples were subject to 35 cycles of PCR with primers designed 
for the A (lanes 1–4), B (lanes 5–8), and negative control elements 
(lane 9–12). A portion of input was used as positive control for PCR 
(lanes 1, 5, and 9). The results indicated that Runx2 binds to these 
putative Runx2 binding A and B elements within Col10a1 promoter 
in vivo (lanes 2 and 6).T
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trophic chondrocytes. Interpreted in the context of the in
vitro and in vivo data, this is most likely explained by direct
transactivation of the Col10a1 promoter by Runx2. Interest-
ingly, as shown in the ulna sections in Fig. 7 A, both
Runx2
 /  and Tg
 / /Runx2
 /  mice had a slightly short-
ened zone of hypertrophy as compared to Runx2
 /  mice.
Similar differences were also observed in sections of the
growth plates of the humerus and radius (unpublished
data). Furthermore, RNA in situ hybridization on distal
femur sections of Runx2
 /  or Runx2
 /  mice using a
Col10a1 riboprobe showed that Col10a1 expression was de-
tected throughout the hypertrophic zone. Moreover, the
Runx2
 /  mice had a shortened hypertrophic zone in the
growth plate region similar to that observed in Tg
 / /
Runx2
 /  mice (Fig. 7 C).
Figure 5.  Col10a1 promoter activity is up-regulated via RUNX2 
binding elements in vitro. (A) Transactivation of Col10a1 via 
RUNX2-binding A and B elements. The RUNX2 expression plasmid 
(RUNX2) was cotransfected in COS7 cells with reporter plasmids 
Min-Col10a1-pA or 8xA/B-Min-Col10a1-pA. Transfection of 
Min-Col10a1-pA with or without RUNX2 expression plasmid 
produced no transactivation (lanes 2 and 3). Transfections of 
8xA/B-Min-Col10a1-pA alone also produced no transactivation 
(lanes 4 and 6). However, the addition of the RUNX2 expression 
plasmid resulted in strong transactivation of 8xA-Min-Col10a1-PA 
and 8xB-Min-Col10a1-pA reporter plasmids, respectively (lanes 5 
and 7). A SV2 gal plasmid was cotransfected as an internal control 
for transfection efficiency. Representative data are presented as fold 
activation relative to the activity obtained with pcDNA3.1 empty 
vector plasmid (lane 1). Each transfection experiment was performed 
in triplicate and the standard deviations are shown by the error bars. 
(B) Contribution of RUNX2 binding sites to 4-kb Col10a1 promoter 
activity. (left) Overexpression of RUNX2 in MCT cells further upreg-
ulates the 4-kb Col10a1 promoter. MCT cells were transfected only 
at the nonpermissive temperature (37 C) with the reporter plasmids 
basCol10a1-pSA -geobpA, 4-kb Col10a1-SA geobpA alone, and 
4-kb Col10a1-SA -geobpA along with the Runx2 expression plas-
mid. A RSV-luc plasmid was cotransfected as internal control for 
transfection efficiency. The endogenous activity of the 4-kb pro-
moter was 10-fold higher than that of the basal promoter, whereas 
over-expression of RUNX2 further increased the promoter activ-
ity. (right) RUNX2 binding sites contribute to 4-kb Col10a1 pro-
moter activity in MCT cells. MCT cells were transfected only at 
nonpermissive temperature (37 C) with reporter plasmids 
basCol10a1-pSA -geobpA, 4-kb Col10a1-SA -geobpA, and mut
4-kb Col10a1-SA -geobpA. When the two Runx2 binding sites 
were mutated, reporter activity was decreased by 35% compared
to that of the wild-type promoter.
Figure 6.  Runx2 directly regulates the activation of the type X 
collagen gene. (A) Runx2 is upregulated in hypertrophic MCT cells. 
When MCT cells were shifted from 32 C to 37 C, Runx2 showed 
two-fold upregulation as assayed by real time RT-PCR (left). 
Meanwhile, Col10a1 showed more than 20-fold up-regulation in 
hypertrophic MCT cells (right). Each real time PCR experiment was 
performed in triplicate and the standard deviations are shown by the 
error bars. Similar results were obtained from three independent 
experiments. (B) Endogenous downregulation of Col10a1 in Runx2
 /  
and Runx2
 /  mouse limbs. Runx2 expression was also decreased 
by 45% in Runx2 heterozygotes (left). Endogenous Col10a1 expres-
sion was also decreased by 50% in Runx2 heterozygotes and 
barely detectable in Runx2
 /  mice as compared to that of the wild-
type littermate control by real time RT-PCR assay (right). Similar re-
sults were obtained from five wild-type, eight Runx2
 /  and two 
Runx2-null mice. One representative set of results is presented here 
with the standard deviations shown by the error bars.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Runx2 in type X collagen gene regulation | Zheng et al. 839
Discussion
Chondrocyte hypertrophy is the terminal step of chondro-
cyte differentiation. The identification of transcription fac-
tors controlling this process is essential for understanding
the molecular mechanisms that specify endochondral ossifi-
cation and the molecular pathogenesis of skeletal dysplasia
such as SMCD. Here, we use the hypertrophic chondro-
cyte–specific molecular marker Col10a1 to delineate cell-
type–specific cis elements and the DNA-binding proteins
that activate them. Our in vitro and in vivo studies show
that Runx2 directly transactivates Col10a1. Although it was
previously reported that treatment with antisense oligonu-
cleotides for Runx2 reduced type X collagen expression in
the chondrogenic cell line ATDC5 and that SMAD-
RUNX2 interactions are important for chondrocyte hyper-
trophy, it was unclear whether Runx2 directly regulates the
activation of the type X collagen gene (Enomoto et al.,
2000; Leboy et al., 2001). Our data provide several lines of
evidence supporting Runx2’s role in the direct regulation of
type X collagen. First, multiple Runx2 binding sites are
found in the type X collagen promoter of mouse as well as
human and chick (Fig. 1, A and B), and some are conserved
between human and mouse (Fig. 1 C). These sites bind to
RUNX2 and can mediate transactivation of the Col10a1
minimal promoter. Moreover, their location in the distal
promoter is in agreement with previous reports of positive
regulatory elements in the corresponding 5  positions in the
human promoter (Beier et al., 1997). Second, the 4-kb pro-
moter containing these sites is activated in MCT cells that
are undergoing hypertrophy and expressing endogenous
type X collagen. Runx2 is also concurrently upregulated. Im-
portantly, mutations of these two sites decrease expression
of the same promoter in hypertrophic cells, whereas over-
expression of Runx2 in the same cells further upregulates the
promoter. Third, the 4-kb promoter, but not the 1.7-kb
mouse promoter, can direct expression selectively though
weakly in hypertrophic chondrocytes. Moreover, it does not
direct expression in resting and proliferating chondrocytes
or in any other tissues including perichondrium that con-
tains high levels of Runx2 in transgenic mice (Eerola et al.,
1996). These in vivo data are correlated with the demonstra-
tion of a genetic interaction between the Runx2 locus and
the activity of the Col10a1 4-kb promoter/reporter trans-
gene. Notably, we also detected decreased Col10a1 expres-
sion in Runx2 heterozygote mice, whereas Col10a1 was
barely detectable in Runx2-null mice.
This paper utilizes a unique type X collagen–expressing
MCT cell line to delineate the cis-acting elements for chon-
drocyte hypertrophy. Compared to the bovine or chicken
primary hypertrophic chondrocytes previously used in the
Figure 7.  Genetic interaction of Runx2 and 
Col10a1. (A) Runx2 and Col10a1 promoter/
reporter transgene. The 4-kb Col10a1 promoter-
 geo transgene (Tg) was bred onto Runx2
 /  and 
Runx2
 /  backgrounds and compared to Runx2
 /  
mice without Tg. X-gal blue staining is much 
weaker in the lower hypertrophic zones of ulna 
of Tg/Runx2
 /  mice (middle) than in that of 
Tg/Runx2
 /  mice (left), whereas no staining is 
observed in the hypertrophic zone of Runx2
 /  
mice (right). The hypertrophic zone (HZ) appeared 
shorter in sections from mice with Runx2
 /  than 
that of Runx2
 /  background. (B) Transgene 
expression in Tg/Runx2
 /  versus Tg/Runx2
 /  
mice. (left) Semi-quantitative densitometric analysis 
of transgene expression in mouse limb sections 
by comparing the gray values generated for blue-
staining cells as described in Materials and methods. 
Sum, total gray value of blue cells; SD, standard 
deviation. (right) Transgene expression was 
decreased by 40% in Runx2 heterozygotes as 
compared to that of the wild-type littermate 
control by real time RT-PCR assay. Similar results 
were obtained from two Tg/Runx2
 /  and three Tg/
Runx2
 /  mice. One representative set of 
results is presented here with the standard deviations 
shown by the error bars. (C) Col10a1 expression 
pattern in Runx2
 /  mice. Runx2
 /  mice showed 
signal of Col10a1 transcripts throughout the hyper-
trophic zone of femur by in situ hybridization 
(left), whereas Runx2
 /  mice also have short-
ened hypertrophic zone as indicated by Col10a1 
expression pattern (right).T
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cell culture studies, the MCT cell line has the advantage
of homogeneity and phenotypic stability (Lefebvre et al.,
1995). Most importantly our results from MCT cells corre-
late with that of transgenic mice. Therefore, MCT cells
could be used to further delineate the cis elements control-
ling chondrocyte hypertrophy and eventually to characterize
the transcription factor(s) specifying this process.
The 4-kb Col10a1 promoter described can direct reporter
expression selectively to lower hypertrophic chondrocytes in
transgenic mice. However, it is likely that additional positive
and negative regulatory elements outside of this 4-kb Col10a1
promoter are also required for tissue-specific expression dur-
ing embryogenesis. This is supported by the detection of weak
 -galactosidase expression in the bone trabeculae of our trans-
genic mice, as well as by the localization of reporter gene ex-
pression primarily in the lower hypertrophic zone, and less so
in the upper hypertrophic zone. Together, these observations
suggest the requirement of additional positive and negative
regulatory elements outside this 4-kb promoter to achieve
high level Col10a1 expression in hypertrophic chondrocytes
in vivo. Runx2 is likely only one of several factors that are re-
quired for this coordinated process. Runx2 is essential for os-
teoblast differentiation and it is also important for chondro-
cyte maturation. It has been shown that Runx2 transcriptional
regulation of collagenase-3, osteopontin, and VEGF is critical
for the transition from chondrogenesis to ossification (Sato et
al., 1998; Jimenez et al., 1999; Zelzer et al., 2001). Runx2
may interact with different factors within osteoblast and hy-
pertrophic chondrocytes to regulate different downstream
genes. It alone is not sufficient to specify chondrocyte hyper-
trophy in all bones, because loss of hypertrophic chondrocytes
is observed only in some of the long bones of Runx2-null mice
(Inada et al., 1999; Kim et al., 1999). Identification of other
transcription factors important for chondrocyte hypertrophy
and their relation with Runx2 will be crucial for our under-
standing of chondrogenesis.
Whether decreased Col10a1 expression might directly af-
fect chondrocyte hypertrophy is still controversial. There
is some evidence to support that haploinsufficiency of
COL10A1 accounts for cases of SMCD (Chan and Ja-
cenko, 1998; Chan et al., 2001; Wilson et al., 2002),
whereas others have pointed to a possible dominant nega-
tive effect (Marks et al., 1999; Gregory et al., 2000). A very
recent study showed that nonsense mutations leads to the
complete degradation of mutant collagen X mRNA in car-
tilage in SMCD (Bateman et al., 2003). Interestingly,
SMCD patients also have an altered zone of hypertrophy
(Wasylenko et al., 1980; Lachman et al., 1988; Nielsen et
al., 2000). However, it appears that chondrocyte hypertro-
phy by itself, at least in mice, does not require type X col-
lagen (Rosati et al., 1994). Instead, defective mineraliza-
tion, altered hematopoiesis, and growth plate compression
were reported in Col10a1-null mice (Kwan et al., 1997;
Gress and Jacenko, 2000). It may be that the structural in-
tegrity of the hypertrophic zone requires normal type X col-
lagen expression in humans and a metaphyseal dysplasia de-
velops in the presence of decreased expression. However,
the same effect may not be seen in mice because of different
biomechanical forces impinging upon metaphyseal devel-
opment in a tetrapod.
From the point of view of skeleton pathogenesis, haploin-
sufficiency of RUNX2 causes cleidocranial dysplasia (CCD),
a dominantly inherited skeletal dysplasia in humans (Mund-
los et al., 1995, 1996, 1997; Lee et al., 1997). The pathog-
nomonic features of CCD include both defective intramem-
branous ossification and defective endochondral ossification
(Cooper et al., 2001). Interestingly, it has been reported that
Runx2
 /  mice exhibit some of the features of CCD includ-
ing delayed closure of the fontanel and hypoplastic clavicles
(Otto et al., 1997). Our findings of decreased Col10a1 ex-
pression and altered chondrocyte hypertrophy in Runx2 het-
erozygote mice suggest that they could also serve as a model
to study the pathogenesis of long bone defects of CCD.
Materials and methods
Electrophoretic mobility shift assay
The mouse Col10a1 BAC was mapped by oligonucleotide-specific South-
ern hybridization analysis of multiple restriction enzyme digested DNA.
The 4-kb XhoI/KpnI promoter fragment was subcloned and sequenced
(GenBank/EMBL/DDBJ accession no. AF326473). EMSA were carried out
essentially as described previously (Zhou et al., 1999) using His-tagged re-
combinant RUNX2 Runt polypeptide and a 
32P-end–labeled double-
stranded probe corresponding to DNA elements A (5 -GATCCTCACCT-
TCTGTGGTTTCTCAGAA-3 ), B (5 -GATCCCCATAAACAACCACCAAAC-
CCAA-3 ), and mutant versions of A or B with mutations outside of the
core sequence (MO: A, 5 -GATCCTCATATTCTGTGGTTTCTCAGAA-3 ;
B, 5 -GATCCCCAGCAACAACCACCAAACCCAA-3  [mutation in italics])
and mutations inside the core sequence (MI: A, 5 -GATCCTCACCTTCTG-
CAGTTTCTCAGAA-3 ; B, 5 -GATCCCCATAAACAACGTCCAAACCCAA-
3  [mutation in italics]). Putative Runx2 binding sites are underlined.
For nuclear extracts, MCT cells were grown at 32 C until subconflu-
ency. They were further incubated at 37 C for 2 d before nuclear extract
preparation. Nuclear extracts were then prepared as described previously
with 10  g/ml of leupeptin and pepstatin in all buffers (Dyer and Herzog,
1995). 3  g of hypertrophic MCT cell nuclear extracts were used for each
binding assay. 50- to 100-fold cold competitor probe, or Runx2 antibody
(Ducy et al., 1997), or preimmune serum were incubated with nuclear ex-
tracts 10 min on ice before addition of probe in parallel experiments. The
MCT cells were provided by B. de Crombrugghe (University of Texas,
Houston, TX). The anti-Runx2 antibody was provided by G. Karsenty (Bay-
lor College of Medicine, Houston, TX).
Chromatin immunoprecipitation assay
Hypertrophic MCT cells were incubated at 37 C for 3 d before formalde-
hyde fixation. Cold PBS (with Protein Inhibitor Cocktail Tablets; Roche)
washing, cell harvesting, and sonication to shear DNA to 500–1,000 bp
was performed according to the manufacturer’s protocol (Upstate Biotech-
nology). Precleared chromatin was incubated with 2  g of the anti-Runx2
antibody (Santa Cruz Biotechnology, Inc.), preimmune antiserum or no an-
tibody and rotated at 4 C for 12 h. Immunoprecipitation, washing, and elu-
tion of immune complex were carried out as described previously (Boyd
and Farnham, 1999). The specific primers for A element, B element, and
the control primers within Col10a1 intron II region were used for PCR am-
plification as described previously (Thomas et al., 2001; Weinmann and
Farnham, 2002).
Transfection studies
The Col10a1 minimal promoter ( 7 bp to  37 bp) was inserted into the
pLuc4 luciferase reporter plasmid (Min-Col10a1-pA; Zhou et al., 1999).
Each of the Runx2 binding elements A or B were concatamerized to form
eight copy fragments, which were inserted upstream of the Col10a1 mini-
mal promoter (8xA/B-Min-Col10a1-pA). Transfections using an expression
plasmid (control pcDNA3.1 or pcDNA3.1/RUNX2), a reporter plasmid
(Min-Col10a1-pA or 8xA/B-Min-Col10a1-pA), and a normalizing plasmid
(pSV2 gal) were performed with the Lipofectamine-plus (GIBCO BRL) re-
agent in COS7 cells, and luciferase and  -galactosidase activities were as-
sayed 24 h after transfection as described previously (Zhou et al., 1999).
Transfections were performed in triplicate at three different doses (0.2, 0.5,
and 1.0  g/well, respectively) to ensure a linear-dose response.
MCT cells were grown at 32 C in standard DME media with 8% FBS
(GIBCO BRL) and 8% CO2 as per published protocol (Lefebvre et al.,T
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1995). Transfection of MCT cells were conducted at both 32 C and 37 C
using reporter plasmids containing a 221-bp basal Col10a1 promoter up-
stream of the  geo reporter (basCol10a1-SA geobpA), the wild-type
Col10a1 4-kb proximal promoter (Col10a1-SA geobpA), or the same
promoter with mutated RUNX2 binding sites A and B (mutCol10a1-
SA geobpA). The mutCol10a1-SA geobpA reporter plasmid was gener-
ated by replacing a Xho/BlpI wild-type fragment with a mutant one within
the 4-kb Col10a1 promoter and it contained the same mutations within the
RUNX2 binding A and B sites as described in the previous paragraph on
the EMSA experiments.
MCT cells were transfected for 6 h using Lipofectamine-plus (GIBCO
BRL), incubated for an additional 48 h at either 32 C or 37 C, and har-
vested for  -galactosidase activity assay. A luciferase expression plasmid
pRSVluc was added to all transfections and used as internal control for
normalizing the cell transfection efficiency. Transfections were also per-
formed in triplicate at three doses to ensure a linear-dose response.
Northern analysis, real time RT-PCR, and in situ hybridization
For Northern hybridization analysis of Col10a1 mRNA derived from MCT
cells grown at either 32 C or 37 C, total RNA was prepared from MCT
cells using TRIzol reagent according to the manufacturer’s protocol
(GIBCO BRL). 10  g RNA was fractionated, transferred to Hybond NH2
nylon membrane (Amersham Biosciences), and hybridized with murine
Col10a1 cDNA (a 1.2-kb BamHI fragment) and Gapdh cDNA (a 300-bp
fragment from the 3  untranslated region) probes as described previously
(Lefebvre et al., 1995). The filter was then autoradiographed for 3 d.
For MCT cells, the same total RNAs for Northern analysis were also
used for cDNA synthesis. Total mouse limb RNAs from littermates with
wild-type, Runx2
 / , or Runx2
 /  background at P1 stage was extracted by
liquid nitrogen frozen, grinded on ice, and followed by TRIzol reagents ex-
traction (GIBCO BRL). cDNA synthesis was performed by using the Super-
script first-strand synthesis system RT-PCR kit (Invitrogen). The primer se-
quences used for PCR amplification for Runx2, Col10a1, transgene (the
bovine growth hormone poly A region in the transgene construct) and
Gapdh was performed using specific primers. The Gapdh gene was used
as
 an internal control of the quantity and quality of the cDNAs. Real time
PCR amplification was performed on LightCycler (Roche) according to the
manufacturer’s protocol and published procedures with modifications
(Pfaffl, 2001). Analysis of the real time PCR results, i.e., the relative gene
expression level, was achieved by using the 2
    C
T method for fold induc-
tion, and 
C
T (the threshold cycle) for the fractional cycle number at which
the amount of amplified target reaches a fixed threshold (Livak and Schmitt-
gen, 2001; Pfaffl, 2001).
For  Col10a1 in situ hybridization, newborn mouse hind limbs were
fixed in 4% PFA in PBS, dehydrated, and embedded in paraffin. Sectioning
and in situ hybridization were carried out as described previously (Al-
brecht, 1998) with the same Col10a1 probe used in the Northern analysis.
Nine distal serial femur sections from each of two Runx2
 /  and one
Runx2
 /  littermates were analyzed. Representative data for comparable
sections are shown.
Generation and histochemical analysis of transgenic mice
The DNA fragment containing the 4-kb Col10a1 promoter followed by
SA geobpA reporter was released from the above-described Col10a1-
SA geobpA construct by ApaI digestion. Purified DNA’s were redissolved
and microinjected into the pronuclei of one-cell ICR X B6C3F1 mouse em-
bryos and implanted into ICR pseudopregnant foster mothers (Hogan et al.,
1986). Transgenic founder mice were analyzed by genomic southern anal-
ysis of tail DNA’s with a 3-kb lacZ-specific probe (Zhou et al., 1995).
Runx2 heterozygote mice were obtained from M. Owen (Lincoln’s Inn
Fields, London, UK) and genotyped by PCR amplification as reported pre-
viously (Otto et al., 1997).
In brief, P1 mice were collected, skinned, and eviscerated. They were
fixed and stained with X-gal (5-bromo-4-chloro-3-indolyl- -D-galactopy-
ranoside) as described previously (Zhou et al., 1995). After staining, mice
were paraffin embedded, sectioned, and counterstained with nuclear fast
red (Poly Scientific R&D Corp.). Sections of all long bones were analyzed
and comparisons were made only among littermates at the same magnifi-
cations. At least 30 sections of each growth plate were analyzed.
For densitometric analysis of transgene expression in Tg/Runx2
 /  and
Tg/Runx2
 /  mouse limb sections, we calculated the gray value of blue
staining cells corresponding to  -galactosidase activity using a microscope
(Axioplan 2; Carl Zeiss MicroImaging, Inc.) and AxioVision 3.1 software
(Carl Zeiss Vision GmbH). Analyses were made by two independent ob-
servers blinded to genotype of the sections. 200 blue staining cells in the
hypertrophic zone were randomly chosen from 20 serial limb sections. A
gray value with standard deviation was generated for each cell. This value
inversely related to the intensity of the blue staining. Average gray values
were calculated for the 200 cells of each genotype. Statistical analysis was
performed with t test.
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